Yulia Ugortsev

Title: Yulia Ugortsev: Innovator in Modified DNase Technology

Introduction

Yulia Ugortsev is a prominent inventor based in Nesher, Israel. She has made significant contributions to the field of biotechnology, particularly in the development of modified DNase proteins. With a total of 2 patents to her name, her work has the potential to impact various medical applications.

Latest Patents

Yulia's latest patents focus on the innovation of Modified DNase I proteins. These proteins are engineered by modifying one or more amino acids of a DNase I protein non-cellularly. The modified DNase I protein demonstrates enhanced DNA hydrolytic activity in the presence of actin, surpassing the activity of its non-modified counterparts. The processes for preparing this modified DNase I protein and its applications include reducing DNA content in sputum and treating diseases associated with excess extracellular DNA in bodily fluids, secretions, or tissues.

Career Highlights

Yulia Ugortsev is currently associated with Protalix Ltd., where she continues to advance her research and development efforts. Her innovative work in the field of modified DNase technology has garnered attention and recognition within the scientific community.

Collaborations

Yulia collaborates with notable colleagues, including Sivan Gelley and Yoseph Shaaltiel, who contribute to her research endeavors and help drive her projects forward.

Conclusion

Yulia Ugortsev's contributions to the field of biotechnology through her innovative work on modified DNase proteins highlight her role as a leading inventor. Her patents not only showcase her expertise but also promise to enhance medical treatments related to DNA management.